Trends in Green Chemistry Open Access

  • ISSN: 2471-9889
  • Journal h-index: 8
  • Journal CiteScore: 1.68
  • Journal Impact Factor: 1.21
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days

Transition metal complexes/organometallic compounds as anticancer/anti HIV drugs or in pharmaceutical industry

EuroSciCon Conference on Chemistry and Green Chemistry Research
December 06-07, 2018 Amsterdam, Netherlands

Prakash Kinthada

Sri Vidyanikethan Engineering college-JNTU University in Ananthapur, India

Posters & Accepted Abstracts: Trends in Green chem


My talk would mainly encompass different transition metal complexes/organometallic compounds that are presently used as drugs, especially anticancer and anti-HIV drugs, apart from anti-inflammatory, antimicrobial, antibacterial and diseases like arthritis and Parkinson’s disease etc. The talk would mainly focus on the use of medicinal chemistry and its application to drug design and development in pharmaceutical industry, especially transition metal complexes and organometallic compounds viz. gold, platinum, palladium and ruthenium apart from copper, cobalt, iron, nickel, zinc, cadmium etc. The main emphasis of my talk would be on different class of ligands, their Schiff’s bases and transition metal complexes especially Au, Pt, Pd and Ru, with the main aim of designing, developing very novel small molecules, as possible and extremely potential candidates as anti-cancer and anti-HIV drugs. The talk would provide an overview of current programs being undertaken in our laboratories, especially focused on the development of potent ligands capable of recognizing binding sites and diverse strategies employed by my group for elucidation of anti-cancer and anti-HIV drug leads to circumvent the problem caused by cis-platin.

Biography :